HLA Class I Antibodies in Patients Awaiting Kidney Transplantation and the Association With Renal Graft Survival

Transplantation Proceedings

Volumn 40, Issue 7, 2008, Pages 2191-2194

  Wu, H H ^a   Tien, Y C ^a   Huang, C I ^a   Chiang, Y J ^a   Chu, S H ^a   Lai, P C ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; HLA ANTIGEN CLASS 1;

ADULT; ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

FOLLOW-UP STUDIES; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WAITING LISTS;

EID: 51249091439     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.043     Document Type: Article

References (13)

1. Sumitran-Holgersson S. HLA-specific alloantibodies and renal graft outcome. Nephrol Dial Transplant 16 (2001) 897
2. Gebel H.M., Bray R.A., and Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 3 (2003) 1488
3. Terasaki P.I., and Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant 4 (2004) 438
4. Dilioglou S., Cruse J.M., and Lewis R.E. High panel reactive antibody against cross-reactive group antigens as a contraindication to renal allotransplantation. Exp Mol Pathol 71 (2001) 73
5. Susal C., and Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 73 (2002) 1269
6. Rodriguez L.M., Paris S.C., Arbelaez M., et al. Kidney graft recipients with pretransplantation HLA class I antibodies and high soluble CD30 are at high risk for graft loss. Hum Immunol 68 (2007) 652
7. Kerman R.H., Susskind B., Buelow R., et al. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection. Transplantation 62 (1996) 201
8. Slavcev A., Lacha J., Honsova E., et al. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Transplant Immunol 14 (2005) 117
9. Terasaki P.I., Ozawa M., and Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 7 (2007) 408
10. Susal C., Pelzl S., Simon T., and Opelz G. Advances in pre- and posttransplant immunologic testing in kidney transplantation. Transplant Proc 36 (2004) 29
11. Susal C., and Opelz G. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I. Hum Immunol 65 (2004) 810
12. Creemers P., Brink J., and Kahn D. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival. Clin Transplant 11 (1997) 134
13. Barama A., Oza U., Panek R., et al. Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants. Clin Transplant 14 (2000) 212